Fragile X: Developing targeted treatments
The NeuroTherapeutics Research Institute is developing targeted treatments for neurodegenerative disorders, such as fragile X-associated tremor/ataxia syndrome, or FXTAS, a debilitating condition discovered by UC Davis physician researchers Randi and Paul Hagerman.
 |
 |
 |
 |
|
|
|
|
| Clinical and TranslationalScience Center |
| Healing |
| Learning |
| Reaching out |
| Working |
| Visiting |